The future of medical devices is bright

Some time ago, the import tariff of more than 30 kinds of medical devices was lowered, or even reduced to zero in the next three or five years. For a while, it raised concerns about China's medical device industry. It is generally believed that domestic medical device enterprises are more difficult to develop into the middle and high-end market, and the whole industry may face difficulties.

But how can we see the sunshine without experiencing rainbow? The impact of tariff reduction may be inevitable. However, the fierce market competition can really make our medical device enterprises grow and grow. In this regard, tariff reduction is not a good thing.

Moreover, the policy promotes the localization of medical equipment and encourages domestic enterprises to develop in the medium and high-end market. Under the promotion of policies, the technical content of medical device enterprises is expected to be greatly improved, and the awareness of innovation is constantly strengthened. Tariff adjustment also reduces the price of core components, which has a certain role in promoting the research and development of high-end products of domestic medical device enterprises. After all, core components are indispensable for the research and development of core technologies.

In addition, the price of high-end imported medical devices is generally high. For patients with demand, even if the tariff is reduced to zero, it is still difficult to bear, which undoubtedly means that domestic medical device enterprises have enough market demand and growth space.

However, the medical device enterprises are too concentrated in the low-end products, and the industrial development starts late, resulting in relatively weak market competitiveness. At the same time, it is hard to change "Chongyang" habits of medical institutions, such as some domestic medical equipment products with high quality and low price, which can be exported to developed countries but can not enter domestic hospitals, so it is conceivable that the trust degree is low.

Therefore, both the policy and the market hope that domestic enterprises can break through the situation that the medium and high-end market has been monopolized by foreign enterprises for a long time.

Capital is also bullish on the medical device industry, which has maintained double-digit growth for many years in a row. According to statistics, industrial output value increased from 67.735 billion yuan in 2008 to 217.591 billion yuan in 2014, and sales revenue increased from 63.949 billion yuan in 2008 to 213.607 billion yuan in 2014, with strong growth.

In addition to the obvious growth trend, the small risk and high profit are also the main reasons why capital is optimistic about the medical device industry. As long as the medical devices have enough core technology, the risk of failure is very low, and the cost of later stage is mainly in consumables, which has a great profit space.

What's more, the investment cycle of medical device industry is short and the demand for capital is small, which is quite in line with the appetite of capital. With the intervention of capital, the development of domestic medical devices is expected to accelerate and break the monopoly situation of foreign enterprises.

Before that, domestic medical devices need to continue to fill the market of imported devices, and devote themselves to research and development to improve their own technical strength, so as to enter the golden decade of development, which is expected to become the largest market in the global medical device market in the next 20 years.